Cheng, Samuel M. S.

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Lau, J. J., Cheng, S. M. S., Leung, K., Lee, C. K., Hachim, A., Tsang, L. C. H., Yam, K. W. H., Chaothai, S., Kwan, K. K. H., Chai, Z. Y. H., et al. (2023) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 198

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong

Mok, C. K. P., Cohen, C. A., Cheng, S. M. S., Chen, C., Kwok, K., Yiu, K., Chan, T., Bull, M., Ling, K. C., Dai, Z., et al. (2022) · Respirology

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 162

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children

Hachim, A., Gu, H., Kavian, O., Mori, M., Kwan, M. Y. W., Chan, W. H., Yau, Y. S., Chiu, S. S., Tsang, O. T. Y., Hui, D. S. C., et al. (2022) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 42

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

Cheng, S. M., Mok, C. K. P., Chan, K. C., Ng, S. S., Lam, B. H., Luk, L. L., Ko, F. W., Chen, C., Yiu, K., Li, J. K., et al. (2022) · Eurosurveillance

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 31

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong

Xie, R., Edwards, K. M., Adam, D. C., Leung, K. S. M., Tsang, T. K., Gurung, S., Xiong, W., Wei, X., Ng, D. Y. M., Liu, G. Y. Z., et al. (2022) · Nature Communications

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 31